These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37747445)

  • 21. Role of vitamin D in risk factors of patients with type 2 diabetes mellitus.
    Zhang Q; Wu Y; Lu Y; Fei X
    Med Clin (Barc); 2020 Mar; 154(5):151-156. PubMed ID: 31255367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic modulation of lipoprotein-associated phospholipase A2 (Lp-PLA2).
    Tselepis AF; Rizzo M; Goudevenos IA
    Curr Pharm Des; 2011 Nov; 17(33):3656-61. PubMed ID: 22074435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of lipoprotein-associated phospholipase A2 mass with asymptomatic cerebral artery stenosis.
    Wang Y; Zhou B; Zhou P; Yao Y; Cui Q; Liu Y; Yang J; Wu S; Zhao X; Zhou Y
    J Cell Mol Med; 2018 Apr; 22(4):2329-2336. PubMed ID: 29424477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].
    Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C
    Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationships between biological novel biomarkers Lp-PLA
    Chen Y; Wang S; Li J; Fu Y; Chen P; Liu X; Zhang J; Sun L; Zhang R; Li X; Liu L
    J Diabetes; 2024 Jul; 16(7):e13574. PubMed ID: 38924255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography.
    Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Thuboi S; Ogita M; Miyazaki T; Nishino A; Yokoyama K; Kurata T; Yatomi Y; Daida H
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):527-33. PubMed ID: 22933444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease.
    Wang Y; Li SS; Na SP; Yu CY; Ji Y; Zhao SL; Xie RJ; Bao YS
    Am J Med Sci; 2016 Oct; 352(4):348-353. PubMed ID: 27776715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein-associated phospholipase A
    Mo J; Chen Z; Wang M; Cheng A; Li J; Pan Y; Jiang Y; Jing J; Wang Y; Pu Y; Li Z
    J Stroke Cerebrovasc Dis; 2024 Nov; 33(11):108012. PubMed ID: 39277067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses.
    Shi Y; Zhang P; Zhang L; Osman H; Mohler ER; Macphee C; Zalewski A; Postle A; Wilensky RL
    Atherosclerosis; 2007 Mar; 191(1):54-62. PubMed ID: 16765356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of lipoprotein-associated phospholipase A2 are associated with coronary atherosclerotic plaque progression in diabetic and non-diabetic patients.
    Zhang S; Wang J; Chen S; Zhang Y; He R; Wang X; Ding F; Hu W; Dai Y; Lu L; Zhang R; Ni J; Chen Q
    BMC Cardiovasc Disord; 2024 May; 24(1):251. PubMed ID: 38745157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study.
    da Silva IT; Timm Ade S; Damasceno NR
    Lipids Health Dis; 2013 Feb; 12():19. PubMed ID: 23413990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target.
    Carlquist JF; Muhlestein JB; Anderson JL
    Expert Rev Mol Diagn; 2007 Sep; 7(5):511-7. PubMed ID: 17892360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein associated phospholipase A2 activity & its correlation with oxidized LDL & glycaemic status in early stages of type-2 diabetes mellitus.
    Garg S; Madhu SV; Suneja S
    Indian J Med Res; 2015 Jan; 141(1):107-14. PubMed ID: 25857502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.
    Maiolino G; Pedon L; Cesari M; Frigo AC; Wolfert RL; Barisa M; Pagliani L; Rossitto G; Seccia TM; Zanchetta M; Rossi GP
    PLoS One; 2012; 7(10):e48171. PubMed ID: 23118945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between plasma lipoprotein-associated phospholipase A2 levels and risk of ischaemic stroke recurrence by gender in the Chinese population.
    Huang J; Lu K; Xie D; Dong S; Zhu F; Lu B; Liu A
    Neurol Res; 2024 Jul; 46(7):679-689. PubMed ID: 38602308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of 25-hydroxyvitamin D, lipoprotein-associated phospholipase A2 and asymptomatic coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang Q; Zhang QQ; He JJ; Dong SQ; Lu Y
    Diabetes Res Clin Pract; 2024 Jun; 212():111681. PubMed ID: 38677367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids.
    Jackisch L; Kumsaiyai W; Moore JD; Al-Daghri N; Kyrou I; Barber TM; Randeva H; Kumar S; Tripathi G; McTernan PG
    Diabetologia; 2018 May; 61(5):1155-1166. PubMed ID: 29427237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.